Constitutive activation of STAT3 has been demonstrated in most human cancers including breast cancer [45], leukemia and lymphoma [46], multiple myeloma [47], and gastric cancer [48], and is associated with a poor prognosis in colorectal cancer [49], gastric cancer [50], and ovarian cancer [51]. Here, STAT3 is linked to breast carcinoma.